1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Prognostic Testing for Prostate Cancer—A Cost-Effectiveness Analysis Comparing a Prostatype P-Score Biomarker Approach to Standard Clinical Practice
- Contribution to journal › Article
-
Mark
The Potential Health Economic Value of Adding Magnetomotive Ultrasound to Current Diagnostic Methods for Detecting Lymph Node Metastases in Rectal Cancer
- Contribution to journal › Article
- 2021
-
Mark
Patient Utilities in Health States Based on Hoehn and Yahr and Off-Time in Parkinson’s Disease : A Swedish Register-Based Study in 1823 Observations
- Contribution to journal › Article
- 2000
-
Mark
Costs of deep foot infections in patients with diabetes mellitus
- Contribution to journal › Article
-
Mark
Pharmacoeconomics and clinical practice guidelines : A survey of attitudes in Swedish formulary committees
- Contribution to journal › Article
- 1998
-
Mark
The effect of changes in treatment patterns on drug expenditure
- Contribution to journal › Article
-
Mark
Price indices of drugs and the switching to new drugs two empirical examples
- Contribution to journal › Article
- 1996
-
Mark
The impact of user charges on the consumption of drugs : Empirical evidence and economic implications
- Contribution to journal › Debate/Note/Editorial
- 1993
-
Mark
Drug Expenditure and New Drug Introductions : The Swedish Experience
- Contribution to journal › Article
